Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-24T10:35:15.088Z Has data issue: false hasContentIssue false

The differential clinical and neurocognitive profiles of COMT SNP rs165599 genotypes in schizophrenia

Published online by Cambridge University Press:  11 April 2005

RAYMOND C.K. CHAN
Affiliation:
Neuropsychology and Applied Cognitive Neuroscience Laboratory, Department of Psychology, Sun Yat-Sen University, Guangzhou, China Department of Psychiatry, the University of Hong Kong, Hong Kong
RONALD Y.L. CHEN
Affiliation:
Department of Psychiatry, the University of Hong Kong, Hong Kong
ERIC Y.H. CHEN
Affiliation:
Department of Psychiatry, the University of Hong Kong, Hong Kong
TOMY C.K. HUI
Affiliation:
Department of Psychiatry, the University of Hong Kong, Hong Kong
ERIC F.C. CHEUNG
Affiliation:
Castle Peak Hospital, Hong Kong
H.K. CHEUNG
Affiliation:
Castle Peak Hospital, Hong Kong
PAK SHAM
Affiliation:
Department of Psychiatry, the University of Hong Kong, Hong Kong Department of Psychiatry, Institute of Psychiatry, London, UK
TAO LI
Affiliation:
Department of Psychiatry, Institute of Psychiatry, London, UK
DAVID COLLIER
Affiliation:
Department of Psychiatry, Institute of Psychiatry, London, UK

Extract

Schizophrenia is characterized by profound disturbances in cognition, emotion, and social functioning. Catechol-O-methyl transferase (COMT) is the important enzyme for the metabolism of monoamines, which play important part in the pathogenesis of schizophrenia. COMT exists in high and low activity forms. The low activity form was found to be an amino acid substitution (Val-108-Met), which reduces the thermostability of the enzyme. This genetic polymorphism has been reported to be associated with schizophrenia and its associated clinical features (Li et al., 1996).

Type
RAPID COMMUNICATION
Copyright
© 2005 The International Neuropsychological Society

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: American Psychiatric Association.
Bray, N.J., Buckland, P.R., Williams, N.M., Williams, H.J., Norton, N., Owen, M.J., & O'Donovan, M.C. (2003). A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. American Journal of Human Genetics, 73, 152161.CrossRefGoogle Scholar
Callicott, J.H., Ramsey, N.F., Tallent, K., Bertolino, A., Knable, M.B., Coppola, R., & Weinberger, D.R. (1998). Functional magnetic resonance imaging brain mapping in psychiatry: Methodological issues illustrated in a study of working memory in schizophrenia. Neuropsychopharmacology, 18, 186196.CrossRefGoogle Scholar
Chan, R.C.K., Chen, E.Y.H., Cheung, E.F.C., & Cheung, H.K. (2004). Executive dysfunctions in schizophrenia: Relationships to clinical manifestations. European Archives of Psychiatry and Clinical Neuroscience, 254, 256262CrossRefGoogle Scholar
Egan, M.F., Goldberg, T.E., Kolachana, B.S., Callicott, J.H., Maz-zanti, C.M., Straub, R.E., Goldman, D., & Weinberger, D.R. (2001). Effect of COMPT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Science, 98, 69176922.CrossRefGoogle Scholar
Glatt, S.J., Faraone, S.V., & Tsuang, M.T. (2003). Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: Meta-analysis of case-control and family-based studies. American Journal of Psychiatry, 160, 469476.CrossRefGoogle Scholar
Gold, J.M., Carpenter, C., Randolph, C., Goldberg, T.E., & Weinberger, D.R. (1997). Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Archives of General Psychiatry, 54, 159165.CrossRefGoogle Scholar
Halperin, J.M., Sharma, V., Greenblatt, E., & Schwartz, S.T. (1991). Assessment of the Continuous Performance Test: Reliability and validity in a nonreferred Sample. Psychological Assessment, 3, 603608.CrossRefGoogle Scholar
Kay, S.R., Fiszbein, A., & Opler, L.A. (1987). The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261276.CrossRefGoogle Scholar
Li, T., Sham, P.C., Vallada, H., Xie, T., Tang, X., Murray, R.M., Liu, X., & Collier, D.A. (1996). Preferential transmission of the high activity allele of COMT in schizophrenia. Psychiatry Genetics, 6, 131133.CrossRefGoogle Scholar
National Institute of Health. (2004). SNP: Single nucleotide polymorphism. Retrieved from http:www.ncbi.nlm.nih.gov/entrez/query.fegi?db=snp
Shifman, S., Bronstein, M., Sternfeld, M., Pisante-Shalom, A., Lev-Lehman, E., Weizman, A., Reznik, I., Spivak, B., Grisaru, N., Karp, L., Schiffer, R., Kotler, M., Strous, R.D., Swartz-Vanetik, M., Knobler, H.Y., Shinar, E., Beckmann, J.S., Yakir, B., Risch, N., Zak, N.B., & Darvasi, A. (2002). A highly significant association between a COMT haplotype and schizophrenia. American Journal of Human Genetics, 71, 12961302.CrossRefGoogle Scholar
Wechsler, D. (1997a). WAIS–III administration and scoring manual. San Antonio, TX: The Psychological Corporation.
Wechsler, D. (1997b). WMS–III administration and scoring manual. San Antonio, TX: The Psychological Corporation.